Android app on Google Play

Jefferies Says Watch for Bottom in Endo Pharma (ENDP)

November 6, 2012 1:05 PM EST Send to a Friend
Get Alerts ENDP Hot Sheet
Price: $67.70 +1.14%

Rating Summary:
    16 Buy, 11 Hold, 3 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 24 | New: 21
Trade ENDP Now!
Join SI Premium – FREE
Jefferies maintained a Buy on Endo Pharmaceuticals Holdings Inc (NASDAQ: ENDP) but cut its price target of $36.00 (from $42.00) in the wake of the company’s weak Q3 earnings report and lower guidance.

"Sentiment couldn't get much worse now, and [Monday's] selling may be a signal for the bottom, but we lower our target to $36 given the miscue," said analyst Corey Davis.

With sentiment at all-time lows, he sees positive risk-reward in the stock.

For an analyst ratings summary and ratings history on Endo Pharmaceuticals Holdings Inc click here. For more ratings news on Endo Pharmaceuticals Holdings Inc click here.

Shares of Endo Pharmaceuticals Holdings Inc closed at $26.73 yesterday.




You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS View, Analyst PT Change

Related Entities

Jefferies & Co, Earnings

Add Your Comment